**Question:** 5-FU is the chemotherapeutic agent of choice for all except -

A. Pancreatic neoplasms
B. Solid tumors involving the central nervous system
C. Infective endocarditis
D. Acute leukemia

**Core Concept:**
5-FU (5-fluorouracil) is a chemotherapeutic agent used in the treatment of various cancers. It belongs to the class of drugs known as antimetabolites, which are analogues of naturally occurring substances in the body that interfere with cellular processes. In the context of cancer treatment, 5-FU acts as a precursor to thymidylate, a nucleoside involved in DNA synthesis. By inhibiting thymidylate synthase, 5-FU interferes with DNA replication and cell division, ultimately leading to cell death in rapidly dividing malignant cells.

**Why the Correct Answer is Right:**
5-FU is commonly used in the treatment of colorectal, pancreatic, and gastric cancers. However, its effectiveness is limited in pancreatic neoplasms (option A) due to the presence of high levels of dihydropyrimidine dehydrogenase (DPD), an enzyme responsible for the rapid degradation of 5-FU. This enzyme is overexpressed in pancreatic cancer cells, reducing the drug's bioavailability and decreasing its efficacy.

5-FU is not typically used in the treatment of solid tumors involving the central nervous system (option B) due to its poor penetration through the blood-brain barrier (BBB). While 5-FU can cross the BBB to some extent, its effectiveness in treating brain tumors is limited.

Infective endocarditis (option C) is an infection involving the heart valves or lining of the heart, typically caused by bacteria like Staphylococcus or Streptococcus species. The treatment of choice for infective endocarditis is antibiotics, not 5-FU, which is used to treat cancer.

Due to the rapid degradation of 5-FU by DPD in leukemia cells (option D), 5-FU is not a suitable treatment option for acute leukemia. Acute leukemia is characterized by the rapid proliferation of abnormal white blood cells, which would be resistant to the effects of 5-FU due to the high levels of DPD.

**Why Each Wrong Option is Incorrect:**

Option A (pancreatic neoplasms):
- High levels of dihydropyrimidine dehydrogenase (DPD) in pancreatic cancer cells leads to rapid degradation of 5-FU, reducing its bioavailability and efficacy.

Option B (central nervous system tumors):
- 5-FU has poor penetration through the blood-brain barrier (BBB), limiting its effectiveness in treating central nervous system tumors.

Option C (infective endocarditis):
- 5-FU is not a suitable treatment for infective endocarditis, which is primarily treated with antibiotics targeting bacterial pathogens.

Option D (acute leukemia):
- High levels of DPD in leukemia cells degrade 5-FU, reducing its effectiveness in treating this type of cancer. Acute leukemia involves the rapid proliferation of abnormal white